Here's Why Novavax Is Trading Higher Today

Novavax, Inc. NVAX shares are trading higher by 7.3% at $237.68, potentially on continued strength after the company on Friday highlighted the publication of positive Phase 2b malaria vaccine data.

Novavax is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases.